Clinical trial NCT04489901: Stria Gravidarum and Olive Oil for Pregnancy Women
Official title: The Effect of Olive Oil on Striae Gravidarum in Primiparous Women: A Randomized Controlled Clinical Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Striae Gravidarum
Pregnancy Related
Keywords: Striae Gravidarum
primipara women
pregnancy
Olive oil
Lead sponsor: Kırklareli University
Sponsor class: OTHER
First posted: 2020-07-28
Enrollment: 156
Sex: FEMALE
Minimum age (years): 20
Maximum age (years): 30
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized controlled clinical trial
Primary purpose: PREVENTION

Brief summary: The aim of this study was to investigate the clinical efficacy of olive oil on the severity and progression of striae gravidarum. This randomized controlled clinical trial included 156 primipara women who were early third trimester. They were randomly allocated into two groups: an experimental group and a control group. Women in the experimental group applied olive oil to their abdomen twice a day in the morning and evening. The control group had no intervention.

Detailed description: The development of striae is one of the most common skin changes in pregnancy. The aim of this study was to investigate the clinical efficacy of olive oil on the severity and progression of striae gravidarum.

This randomized controlled clinical trial included 156 primipara women who were early third trimester. They were randomly allocated into two groups: an experimental group and a control group. Women in the experimental group applied olive oil to their abdomen twice a day in the morning and evening. The control group had no intervention.Data were collected using maternal information form, Fitzpatrick Skin Type Scale and Davey's Severity Score.

Eligibility criteria: Inclusion Criteria:

* being in the age group of 20-30 years, early third trimester (being at the 28th week of gestation), having a singleton pregnancy, being primiparous, and volunteering to participate in the study.

Exclusion Criteria:

* having a chronic disease (such as diabetes or hypertension), having striae (before 28th gestation week), having traces of scar tissue from adolescence, using cortisone cream or another kind of topical cream, having polyhydramnios, having threatened preterm labor or preterm delivery, having any disease of the skin, taking any medication regularly, having a problem preventing communication, using pharmacological or non-pharmacological methods (undergoing pharmacotherapy) to reduce nausea, and undergoing psychiatric treatment (psychotherapy).

Primary outcomes:
measure: Prevent the severity and progression of SG
timeFrame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
measure: Maternal information form
timeFrame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
measure: The Fitzpatrick Skin Type Scale
timeFrame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
measure: Davey's Severity Score
timeFrame: All the participating women were followed-up from the 28th week of gestation to the 37th week of gestation.
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Medipol University
city: Kırklareli
country: Turkey
facility: Kırklareli University
Study officials:
affiliation: Kırklareli University
name: AYCA S KIRCA, Phd
role: STUDY_DIRECTOR
References:
citation: Solt Kirca A, Kanza Gul D. Effects of Olive Oil on Striae Gravidarum in Primiparous Women: A Randomized Controlled Clinical Study. Altern Ther Health Med. 2022 May;28(4):34-39.